Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat.
To test the hypothesis that the renin-angiotensin system is involved in the development of the pulmonary vascular patholigic changes of chronic alveolar hypoxia, two groups of rats were exposed to 0.5 atm. for 21 days. One group received SQ 20,881 (2 mg. per kg.) every 8 hours subcutaneously and the second group received normal saline. A third group of rats was maintained at normobaria. Rats receiving SQ 20,881 had significantly less pulmonary arterial hypertrophy and right ventricular hypertrophy than hypobaric animals. SQ 20,881-treated rats showed a significant increase in adrenal weight but a marked reduction in the thickness of the zona glomerulosa, as compared with the other groups. Our findings indicate that angiotensin II is necessary in the development of the pulmonary vascular structural changes of chronic alveolar hypoxia.
D000311:Adrenal Glands / Q000473:pathology; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001835:Body Weight; D005260:Female; D006400:Hematocrit; D000860:Hypoxia / Q000201:enzymology / Q000473:pathology*; D007279:Injections, Subcutaneous; D009842:Oligopeptides / Q000494:pharmacology*; D009929:Organ Size; D011651:Pulmonary Artery / Q000473:pathology*; D051381:Rats; D013722:Teprotide / Q000494:pharmacology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D009842:Oligopeptides; D013722:Teprotide